EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

The rise, fall, and resurgence of phage therapy for urinary tract infection

Jacob J Zulk iD, Kathryn A Patras iD, Anthony W Maresso iD

EcoSal Plus · 2024

DOI: 10.1128/ecosalplus.esp-0029-2023 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift EcoSal Plus, 2024. Verfasst von Jacob J Zulk und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas, USA. Hauptthemen laut MEDLINE: Phage Therapy, Urinary Tract Infections, Uropathogenic Escherichia coli, Bacteriophages. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 187 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Institutes of Health NIDDK, National Institutes of Health NIAID, NIAID NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In the face of rising antimicrobial resistance, bacteriophage therapy, also known as phage therapy, is seeing a resurgence as a potential treatment for bacterial infections including urinary tract infection (UTI). Primarily caused by uropathogenic Escherichia coli , the 400 million UTI cases annually are major global healthcare burdens and a primary cause of antibiotic prescriptions in the outpatient setting. Phage therapy has several potential advantages over antibiotics including the ability to disrupt bacterial biofilms and synergize with antimicrobial treatments with minimal side effects or impacts on the microbiota. Phage therapy for UTI treatment has shown generally favorable results in recent animal models and human case reports. Ongoing clinical trials seek to understand the efficacy of phage therapy in individuals with asymptomatic bacteriuria and uncomplicated cystitis. A possible challenge for phage therapy is the development of phage resistance in bacteria during treatment. While resistance frequently develops in vitro and in vivo , resistance can come with negative consequences for the bacteria, leaving them susceptible to antibiotics and other environmental conditions and reducing their overall virulence. “Steering” bacteria toward phage resistance outcomes that leave them less fit or virulent is especially useful in the context of UTI where poorly adherent or slow-growing bacteria are likely to be flushed from the system. In this article, we describe the history of phage therapy in treating UTI and its current resurgence, the state of its clinical use, and an outlook on how well-designed phage therapy could be used to “steer” bacteria toward less virulent and antimicrobial-susceptible states.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Phage TherapyUrinary Tract InfectionsUropathogenic Escherichia coliBacteriophagesAnti-Bacterial AgentsHumansAnimalsEscherichia coli InfectionsBiofilmsDrug Resistance, Bacterial

Stichwörter der Autor:innen

antimicrobial resistancebacteriophage resistancephage therapyurinary tract infectionuropathogenic E. coli

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas, USA.
  • Alkek Center for Metagenomics and Microbiome Research, Baylor College of Medicine, Houston, Texas, USA.
  • Department of Molecular Virology and Microbiology, Tailored Antibacterials and Innovative Laboratories for Phage (Φ) Research (TAILΦR), Baylor College of Medicine, Houston, Texas, USA.

ORCID-Profile: Jacob J Zulk, Kathryn A Patras, Anthony W Maresso

Förderung

  • National Institutes of Health NIDDK
  • National Institutes of Health NIAID
  • NIAID NIH HHS
  • NIDDK NIH HHS
  • Office for Science and Technology of the Embassy of France in the United States (OST)

Zitieren

APA

Zulk, J. J., Patras, K. A., & Maresso, A. W. (2024). The rise, fall, and resurgence of phage therapy for urinary tract infection. EcoSal Plus. https://doi.org/10.1128/ecosalplus.esp-0029-2023

Vancouver

Zulk JJ, Patras KA, Maresso AW. The rise, fall, and resurgence of phage therapy for urinary tract infection. EcoSal Plus. 2024. doi:10.1128/ecosalplus.esp-0029-2023

BibTeX
@article{Zulk2024,
  author = {Zulk, Jacob J and Patras, Kathryn A and Maresso, Anthony W},
  title = {The rise, fall, and resurgence of phage therapy for urinary tract infection},
  journal = {EcoSal Plus},
  year = {2024},
  doi = {10.1128/ecosalplus.esp-0029-2023}
}
Kostenlos starten →